Literature DB >> 11231943

Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation.

J M Mariadason1, A Velcich, A J Wilson, L H Augenlicht, P R Gibson.   

Abstract

BACKGROUND & AIMS: The short-chain fatty acid butyrate induces cell cycle arrest, differentiation, and apoptosis in colon cancer cells, but often induces opposite effects in normal colonic epithelial cells. We determined whether response to butyrate is dependent on the basal differentiation status of colonic epithelial cells.
METHODS: Caco-2 cells at progressive stages of differentiation were treated with butyrate, and endpoints were measured.
RESULTS: Response of Caco-2 cells to butyrate was dependent on their differentiation status. Butyrate maximally stimulated cell cycle arrest, apoptosis, alkaline phosphatase activity, transepithelial resistance, cell migration, urokinase receptor expression, and interleukin 8 secretion in undifferentiated Caco-2 cells, whereas differentiated Caco-2 cells were essentially resistant to these effects. Consistently, butyrate selectively induced histone hyperacetylation in undifferentiated Caco-2 cells. This resistance was also observed during HT29cl.19A cell differentiation, but not in the nondifferentiating SW620 cell line. Finally, the rate of butyrate use significantly increased as Caco-2 cells underwent spontaneous differentiation.
CONCLUSIONS: Colonic epithelial cells become progressively more refractory to the effects of butyrate during absorptive cell differentiation. We postulate that this resistance is caused by the rapid use of butyrate by differentiated Caco-2 cells, which likely results in low intracellular concentrations and subsequently in its inability to inhibit histone deacetylase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231943     DOI: 10.1053/gast.2001.22472

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

1.  Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells.

Authors:  Jacinta Serpa; Francisco Caiado; Tânia Carvalho; Cheila Torre; Luís G Gonçalves; Cristina Casalou; Pedro Lamosa; Margarida Rodrigues; Zhenping Zhu; Eric W F Lam; Sérgio Dias
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Intestinal epithelial-specific PTEN inactivation results in tumor formation.

Authors:  Do-Sun Byun; Naseem Ahmed; Shannon Nasser; Joongho Shin; Sheren Al-Obaidi; Sanjay Goel; Georgia A Corner; Andrew J Wilson; Dustin J Flanagan; David S Williams; Leonard H Augenlicht; Elizabeth Vincan; John M Mariadason
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

3.  Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent.

Authors:  Arkadiusz Orchel; Zofia Dzierzewicz; Beata Parfiniewicz; Ludmiła Weglarz; Tadeusz Wilczok
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.

Authors:  G Pedersen; L Andresen; M W Matthiessen; J Rask-Madsen; J Brynskov
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer.

Authors:  Missak Haigentz; Mimi Kim; Catherine Sarta; Juan Lin; Roger S Keresztes; Bruce Culliney; Anu G Gaba; Richard V Smith; Geoffrey I Shapiro; Lucian R Chirieac; John M Mariadason; Thomas J Belbin; John M Greally; John J Wright; Robert I Haddad
Journal:  Oral Oncol       Date:  2012-06-28       Impact factor: 5.337

6.  Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.

Authors:  Nuria Camarero; Alícia Nadal; María José Barrero; Diego Haro; Pedro F Marrero
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

Review 7.  Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers.

Authors:  Brahma N Singh; Hongyuan Zhou; Jinping Li; Tracy Tipton; Bin Wang; Guo Shao; E Nickolas Gilbert; Qiang Li; Shi-Wen Jiang
Journal:  Future Oncol       Date:  2011-12       Impact factor: 3.404

8.  Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines.

Authors:  A Buda; D Qualtrough; M A Jepson; D Martines; C Paraskeva; M Pignatelli
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues.

Authors:  Ke Long Jin; Jhang Ho Pak; Jeong-Yeol Park; Won Ho Choi; Joo-Yong Lee; Jong-Hyeok Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

10.  HDAC4 promotes growth of colon cancer cells via repression of p21.

Authors:  Andrew J Wilson; Do-Sun Byun; Shannon Nasser; Lucas B Murray; Kanyalakshmi Ayyanar; Diego Arango; Maria Figueroa; Ari Melnick; Gary D Kao; Leonard H Augenlicht; John M Mariadason
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.